Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven versus normal saline for fluid resuscitation in severe sepsis
2006-004350-25Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Dec 2006
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial in sepsis comparing Voluven arm with Sodium chloride 0.9% arm (2 arms). Primary endpoints: Amount of study drug required to achieve initial hemodynamic stabilization and Total enteral calories during the first 7 days after initial hemodynamic stabilization. Started Dec 2006; status: completed.
02
Drugs
Volulytesodium chloride
03
Conditions
sepsis
Beyond the preview
Go deeper on 2006-004350-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004350-25.